Judgment of the Court (Third Chamber) of 14 January 2010.   Association générale de l’industrie du médicament (AGIM) ASBL and Others (C-471/07 and C-472/07); Janssen Cilag SA (C-471/07) and Sanofi-Aventis Belgium SA (C-472/07) v Belgian State.   References for a preliminary ruling: Conseil d'État - Belgium.   Directive 89/105/EEC - Transparency of measures regulating the pricing of medicinal products for human use - Article 4(1) - Direct effect - Price freeze. 